NUR 520 Module 8 Screening Paper Example

A Test That Finds Half: Screening Accuracy, Predictive Value and the Case Against COPD Screening in Adults Without Symptoms

[Student Name]

Southern New Hampshire University

NUR 520: Epidemiological and Biostatistical Applications in Healthcare

Module Eight Assignment

[Instructor Name]

[Date]

A Test That Finds Half: Screening Accuracy, Predictive Value and the Case Against COPD Screening in Adults Without Symptoms

Screening means testing people who have no symptoms to find disease earlier than it would otherwise be found. It is attractive for a condition like COPD, which is often diagnosed late. But screening is worthwhile only when the test is accurate enough, when early detection leads to better outcomes and when the benefits outweigh the harms. This paper evaluates a real COPD screening tool, calculates how its predictive value would change in Coös County, New Hampshire, where smoking is common, and explains the national recommendation on screening. It argues that even a reasonably specific tool finds only about half of undiagnosed cases, that predictive value depends heavily on the population screened, and that without evidence that early treatment of symptom-free COPD improves outcomes, the nurse's role is case finding in people with symptoms rather than screening everyone.

Accuracy Measures

Four numbers describe a screening test. Two of them, sensitivity and specificity, are properties of the test: of everyone who truly has COPD, what share does the tool flag, and of everyone who truly does not, what share does it clear? The other two, the positive and negative predictive values, belong to the person holding a result. A smoker in Berlin, New Hampshire, who is told the screen was positive wants to know the odds that the finding is real, and those two values supply the answer, and because they are computed among people grouped by their result rather than by their true status, they rise and fall with the share of the screened group who are actually ill (Celentano & Szklo, 2019).

The CAPTURE Tool

Martinez et al. (2023) evaluated CAPTURE, a five-item questionnaire combined with a peak expiratory flow measurement for patients with intermediate scores, in 4,325 primary care patients aged 45 to 80 across seven U.S. practice-based research networks, none of whom had a COPD diagnosis. Everyone also had spirometry. Only 110 patients, 2.5%, had undiagnosed, clinically significant COPD. CAPTURE identified 53 of them, a sensitivity of 48.2% (95% CI 38.6% to 57.9%), and correctly classified 88.6% of those without significant COPD as negative, a specificity of 88.6% (87.6% to 89.6%). The area under the receiver operating characteristic curve across thresholds was 0.81.

What the Results Mean for a Patient

Using the published figures, the predictive values in the study population can be calculated. With 110 true cases and 53 detected, about 480 of the 4,215 patients without significant COPD would have tested positive, so roughly 53 of 533 positive results, about 10%, reflected true disease. The negative predictive value was about 98.5%. These values were calculated for this paper from the reported sensitivity, specificity and prevalence. In practice, nine of ten positive screens in that population would lead to spirometry that finds no clinically significant COPD, while a negative result is reassuring but would still miss about half of the patients who have the disease.

Predictive Value in Coös County

Predictive value would be higher in a population where undiagnosed COPD is more common. Suppose the tool were used among adult smokers in Coös, and suppose undiagnosed clinically significant COPD were present in 10% of them, an assumption chosen for illustration because no county figure exists. With the same sensitivity and specificity, the positive predictive value would rise to about 32% and the negative predictive value would fall to about 94%. At an assumed 20% prevalence, the positive predictive value would be about 51%. Table 1 summarizes these calculations.

Table 1

Predictive Values of the CAPTURE Tool at Different Prevalences

Note. Calculated for this paper using the sensitivity (48.2%) and specificity (88.6%) reported by Martinez et al. (2023). The 10% and 20% prevalences are illustrative assumptions, not county data.

Criteria for a Screening Program

Classic criteria for a worthwhile screening program ask whether the condition is an important health problem, whether it has a detectable early stage, whether an acceptable and accurate test exists and whether early treatment improves outcomes compared with treatment after symptoms appear (Celentano & Szklo, 2019). COPD meets the first two criteria. The test criterion is partly met: CAPTURE is simple and acceptable, but it misses about half of cases. The last criterion is where screening fails. The U.S. Preventive Services Task Force reviewed the evidence and concluded with moderate certainty that screening asymptomatic adults for COPD has no net benefit, and it recommends against it, a D recommendation (US Preventive Services Task Force et al., 2022). The central problem is that treating mild, symptom-free COPD has not been shown to change the course of disease.

Harms and Costs of Screening

Screening is not free of harm. Each false positive leads to spirometry, a visit and often anxiety, and in a rural county each spirometry referral may mean a long drive and a missed day of work. A positive screen can also lead to labels and prescriptions for inhalers in people whose symptoms and lung function do not warrant them. False negatives carry a different harm: people told they screened negative may be less likely to seek care when symptoms develop. In a region where specialty services are scarce, filling spirometry schedules with screen-positive people who turn out not to have disease could delay testing for people with real symptoms, which is the opposite of what the county needs.

The Nursing Role: Case Finding, Not Screening

The recommendation does not mean ignoring COPD. It applies to adults who do not recognize or report respiratory symptoms. For people with symptoms such as chronic cough, sputum or breathlessness, especially smokers, evaluation with spirometry is appropriate, and that is where nurses can make a difference in Coös. Nurses in primary care can ask every smoker about symptoms at each visit, use a structured question set, arrange spirometry for those who report symptoms and pair every visit with cessation support, which helps whether or not COPD is present. Tools like CAPTURE may be more useful in that symptomatic, higher-prevalence group, where the table shows their predictive value is much higher.

Conclusion

CAPTURE is a practical tool with good specificity, but it finds only about half of undiagnosed COPD, and in a typical primary care population nine of ten positive results are false alarms. Its predictive value improves in populations where COPD is more common, such as smokers with symptoms. Because early treatment of symptom-free COPD has not been shown to help, the national recommendation against screening asymptomatic adults is sound. For Coös, the better investment is case finding in people with symptoms and consistent cessation support.

References

Celentano, D. D., & Szklo, M. (2019). Gordis epidemiology (6th ed.). Elsevier.

Martinez, F. J., Han, M. K., Lopez, C., Murray, S., Mannino, D., Anderson, S., Brown, R., Dolor, R., Elder, N., Joo, M., Khan, I., Knox, L. M., Meldrum, C., Peters, E., Spino, C., Tapp, H., Thomashow, B., Zittleman, L., Make, B., . . . CAPTURE Study Group. (2023). Discriminative accuracy of the CAPTURE tool for identifying chronic obstructive pulmonary disease in US primary care settings. JAMA, 329(6), 490-501. https://doi.org/10.1001/jama.2023.0128

US Preventive Services Task Force, Mangione, C. M., Barry, M. J., Nicholson, W. K., Cabana, M., Caughey, A. B., Chelmow, D., Coker, T. R., Davis, E. M., Donahue, K. E., Jaén, C. R., Kubik, M., Li, L., Ogedegbe, G., Pbert, L., Ruiz, J. M., Stevermer, J., Tseng, C.-W., & Wong, J. B. (2022). Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force reaffirmation recommendation statement. JAMA, 327(18), 1806-1811. https://doi.org/10.1001/jama.2022.5692